Published in Am J Physiol Gastrointest Liver Physiol on December 18, 2003
Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. Int J Clin Exp Med (2009) 0.90
The mechanism of dietary cholesterol effects on lipids metabolism in rats. Lipids Health Dis (2010) 0.88
Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats. Dig Dis Sci (2013) 0.81
FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels. J Lipid Res (2013) 0.81
Dietary chitosan enhances hepatic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats. Nutr Res Pract (2007) 0.78
Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery. J Obes (2016) 0.75
Ethylene biosynthesis and signaling networks. Plant Cell (2002) 5.37
Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol (2005) 5.11
Single-layer MoS2 phototransistors. ACS Nano (2011) 3.43
Growth of large-area and highly crystalline MoS2 thin layers on insulating substrates. Nano Lett (2012) 2.81
The Arabidopsis Rop2 GTPase is a positive regulator of both root hair initiation and tip growth. Plant Cell (2002) 2.76
Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol (2005) 2.64
The ROP2 GTPase controls the formation of cortical fine F-actin and the early phase of directional cell expansion during Arabidopsis organogenesis. Plant Cell (2002) 2.38
Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A (2004) 2.32
Transient receptor potential channels in cardiovascular function and disease. Circ Res (2006) 2.20
Active Arf6 recruits ARNO/cytohesin GEFs to the PM by binding their PH domains. Mol Biol Cell (2007) 2.15
Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest (2002) 2.12
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst (2005) 2.12
Brain tissue segmentation based on DTI data. Neuroimage (2007) 2.06
Counseling parents before prenatal diagnosis: do we need to say more about the sex chromosome aneuploidies? Am J Med Genet A (2013) 1.98
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol (2002) 1.94
Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet (2003) 1.85
Splenic injury as a complication of colonoscopy: a case series. Am J Gastroenterol (2009) 1.83
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology (2011) 1.69
Temporal transcriptional response to ethylene gas drives growth hormone cross-regulation in Arabidopsis. Elife (2013) 1.64
Single-layer semiconducting nanosheets: high-yield preparation and device fabrication. Angew Chem Int Ed Engl (2011) 1.60
Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism (2005) 1.58
Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Invest (2014) 1.55
Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone. J Gastroenterol (2005) 1.43
Multiple activities for Arf1 at the Golgi complex. Biochim Biophys Acta (2005) 1.41
Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J Lipid Res (2008) 1.39
Overview of epidermolysis bullosa. J Dermatol (2010) 1.37
Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J Lipid Res (2010) 1.36
The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J Lipid Res (2006) 1.34
NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols. J Biol Chem (2006) 1.32
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1. Am J Physiol Gastrointest Liver Physiol (2009) 1.31
A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med (2004) 1.28
Sugar micro needles as transdermic drug delivery system. Biomed Microdevices (2005) 1.28
Plasma membrane-associated ROP10 small GTPase is a specific negative regulator of abscisic acid responses in Arabidopsis. Plant Cell (2002) 1.28
Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage. Circ Res (2005) 1.25
Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J Lipid Res (2003) 1.24
Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia. Clin Gastroenterol Hepatol (2004) 1.24
Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res (2005) 1.24
Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy. J Clin Invest (2014) 1.19
Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6. J Physiol (2008) 1.19
Characterization of a highly efficient blue-shifted channelrhodopsin from the marine alga Platymonas subcordiformis. J Biol Chem (2013) 1.19
Fabrication of flexible MoS2 thin-film transistor arrays for practical gas-sensing applications. Small (2012) 1.17
Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol (2006) 1.17
Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer. J Biol Chem (2011) 1.16
Membrane stretch-induced activation of a TRPM4-like nonselective cation channel in cerebral artery myocytes. J Pharmacol Sci (2007) 1.15
Single-layer MoS2-based nanoprobes for homogeneous detection of biomolecules. J Am Chem Soc (2013) 1.15
Intramolecular proton transfer in channelrhodopsins. Biophys J (2013) 1.14
Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. J Lipid Res (2002) 1.13
The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression. Cell Res (2009) 1.12
Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res (2011) 1.11
Interleukin-1beta enhances the effect of serum deprivation on rat annular cell apoptosis. Apoptosis (2007) 1.10
Interlayer breathing and shear modes in few-trilayer MoS2 and WSe2. Nano Lett (2013) 1.08
Results of clubfoot management using the Ponseti method: do the details matter? A systematic review. Clin Orthop Relat Res (2014) 1.07
Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase. Metabolism (2004) 1.07
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J Lipid Res (2005) 1.06
Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol (2009) 1.06
Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J x CASA/Rk intercross. Proc Natl Acad Sci U S A (2002) 1.06
Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology (2006) 1.06
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer (2005) 1.06
FPGA-based reconfigurable processor for ultrafast interlaced ultrasound and photoacoustic imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2012) 1.05
Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.05
Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J Hepatol (2005) 1.05
Fabrication of graphene nanomesh by using an anodic aluminum oxide membrane as a template. Adv Mater (2012) 1.05
Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. Am J Respir Crit Care Med (2015) 1.04
A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol (2010) 1.03
Low bone mineral status in adolescent idiopathic scoliosis. Eur Spine J (2008) 1.02
Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS. J Lipid Res (2008) 1.02
Centimeter-long and large-scale micropatterns of reduced graphene oxide films: fabrication and sensing applications. ACS Nano (2010) 1.01
Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci (2005) 1.01
Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci U S A (2003) 1.01
The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. J Biol Chem (2010) 1.01
Expression of leptin and its functional receptor on disc cells: contribution to cell proliferation. Spine (Phila Pa 1976) (2008) 1.01
Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS. J Lipid Res (2006) 1.00
The Hsp40 family chaperone protein DnaJB6 enhances Schlafen1 nuclear localization which is critical for promotion of cell-cycle arrest in T-cells. Biochem J (2008) 1.00
Co-registered pulse-echo/photoacoustic transvaginal probe for real time imaging of ovarian tissue. J Biophotonics (2013) 1.00
Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy. Hepatol Res (2005) 0.99
Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am J Physiol Gastrointest Liver Physiol (2003) 0.99
Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology (2005) 0.99
FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am J Physiol Gastrointest Liver Physiol (2005) 0.99
Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res (2004) 0.99
Ursodeoxycholic acid: Mechanism of action and novel clinical applications. Hepatol Res (2007) 0.97
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol (2013) 0.97
Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat. Metabolism (2006) 0.97
Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2009) 0.96
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol (2006) 0.96
Transparent, flexible, all-reduced graphene oxide thin film transistors. ACS Nano (2011) 0.96